MEDGm vs yourEra for weight loss
MEDGm and yourEra side by side: what each costs as your dose rises, which medications each prescribes, and the terms behind the price.
By the RxLineup editorial team · Fact-checked against provider sites and FDA labels · Updated
Only providers that pay us appear in our rankings and reviews, and we’re paid when you sign up through our links. How we make money
- Safety: GLP-1 medications carry a boxed warning for thyroid C-cell tumors. Read before you start
Higher score
MEDGm
Rated 9.0 out of 10, Excellent
From $299/mo
Tirzepatide $269/mo
yourEra
Rated 8.8 out of 10, Excellent
From $89/mo
Tirzepatide $99/mo
The verdict
YourEra is $104 a month cheaper for compounded semaglutide ($65/mo, 12 mo prepaid, vs $169/mo, 12 mo prepaid); yourEra is $170 a month cheaper for compounded tirzepatide ($99/mo, 12 mo prepaid, vs $269/mo, 12 mo prepaid). Only MEDGm offers oral compounded GLP-1, Zepbound, Wegovy and 2 others. MEDGm scores higher overall (9.0 vs 8.8), with its widest lead on medication options (9.0 vs 6.5).
Choose MEDGm if…
You want the option of oral compounded GLP-1, Zepbound, Wegovy and 2 others and a better medication options score (9.0 vs 6.5).
Choose yourEra if…
You want compounded semaglutide for $65/mo, compounded tirzepatide for $99/mo and a better price-and-value score (9.5 vs 8.0).
What’s different
The seven places where MEDGm and yourEra differ for weight loss, from the prices and terms each publishes.
| Difference | MEDGm | yourEra |
|---|---|---|
| Compounded semaglutide | $169/mo | $65/mo |
| Compounded tirzepatide | $269/mo | $99/mo |
| Oral compounded GLP-1 | $239/mo | Not offered |
| Zepbound | Offered; price not published | Not offered |
| Wegovy | Offered; price not published | Not offered |
| Wegovy pill | Offered; price not published | Not offered |
| Ozempic | Offered; price not published | Not offered |
Head to head
| Feature | MEDGm review | yourEra review |
|---|---|---|
| Overall score | 9.0/10 Higher | 8.8/10 |
| Starting price | $299/mo | $89/mo Lower |
| Compounded semaglutide | $169/mo billed $2,028 for 12 months | $65/mo billed $780 for 12 months Lower |
| Compounded tirzepatide | $269/mo billed $3,228 for 12 months | $99/mo billed $1,188 for 12 months Lower |
| Brand-name options | Zepbound, Wegovy, Wegovy pill, Ozempic | None |
| Same price at every dose | Yes | Yes |
| Membership | None | None |
| Insurance | – | Self-pay |
| Refunds | 100% refund if the provider determines you don’t qualify | Your card is charged only if a clinician prescribes, and you get a full refund if you cancel before the order ships |
| Availability | All 50 states and DC (its terms say some medications may not be available in every state) | All 50 states (availability of specific treatments varies by state) |
| Next step | Visit MEDGm for MEDGm (opens in a new tab) | Visit yourEra for yourEra (opens in a new tab) |
– Not published by the provider.
Scores compared
Both programs are scored out of 10 on the same five weighted criteria. How we rate
MEDGmyourEra
-
Price & value 30%
-
Clinical care 25%
-
Medication options 20%
-
Transparency 15%
-
Experience 10%
MEDGm pros and cons
Strengths
- Lab work and metabolic report included
- Unlimited clinician access by video or chat
- Same price at any dose
- Compounded tablets plus brand-name Zepbound, Wegovy and Ozempic
- Pharmacies named; HSA/FSA eligible
Drawbacks
- Month to month is $299 for semaglutide after the first month
- No refund for the current month on monthly plans
- Brand-name medication prices not published
- Cancel at least 72 hours before renewal
yourEra pros and cons
Strengths
- Semaglutide $65/month on the 12-month plan, $89 month to month
- Same price at every dose, renewing at the same rate
- Charged only if prescribed
- Pharmacies named in its terms; HSA/FSA eligible
Drawbacks
- Lowest price is billed yearly ($780)
- No refund once an order ships
- Compounded medication only
- Labs and coaching only in a membership listed as coming soon
Safety
One of these treatments carries an FDA boxed warning, the strongest warning on a label: GLP-1 medications.
- SemaglutideNot FDA-approved
- GLP-1 medications carry a boxed warning for thyroid C-cell tumors and are not for people with a personal or family history of medullary thyroid carcinoma or MEN 2. FDA label
- TirzepatideNot FDA-approved
- GLP-1 medications carry a boxed warning for thyroid C-cell tumors and are not for people with a personal or family history of medullary thyroid carcinoma or MEN 2. FDA label
- Compounded GLP-1sCompounded; not FDA-approved
- GLP-1 medications carry a boxed warning for thyroid C-cell tumors and are not for people with a personal or family history of medullary thyroid carcinoma or MEN 2.
- ZepboundFDA-approved for long-term weight reduction (adults)
- GLP-1 medications carry a boxed warning for thyroid C-cell tumors and are not for people with a personal or family history of medullary thyroid carcinoma or MEN 2.
- WegovyFDA-approved for long-term weight reduction (adults, and children 12 and older)
- GLP-1 medications carry a boxed warning for thyroid C-cell tumors and are not for people with a personal or family history of medullary thyroid carcinoma or MEN 2.
- Wegovy pillFDA-approved for long-term weight reduction (adults)
- GLP-1 medications carry a boxed warning for thyroid C-cell tumors and are not for people with a personal or family history of medullary thyroid carcinoma or MEN 2.
- OzempicFDA-approved drug; used off-label here
- GLP-1 medications carry a boxed warning for thyroid C-cell tumors and are not for people with a personal or family history of medullary thyroid carcinoma or MEN 2.
Not medical advice. A licensed clinician decides whether a treatment is right for you; read the full prescribing information before you start.
Not sure which program fits?
Answer five quick questions about budget, medication and insurance, and we’ll rank the programs for you. No email or sign-up needed.